Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 5/2009

01.05.2009 | Inflammatory Disorders

Ocular involvement in Adamantiades-Behçet’s disease in Berlin, Germany

verfasst von: Lothar Krause, Anne-Katrin Köhler, Andreas Altenburg, Nestor Papoutsis, Christos C. Zouboulis, Uwe Pleyer, Andrea Stroux, Michael H. Foerster

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 5/2009

Einloggen, um Zugang zu erhalten

Abstract

Background

Epidemiological studies demonstrate a prevalence of Adamantiades-Behçet’s disease (ABD) in the range of 0.12–420 per 100,000 inhabitants, with the highest rates in Istanbul, Turkey, and the lowest rates in the USA. Ophthalmological data on the prevalence of ocular involvement are limited for ABD in Germany, because most epidemiological studies are based on rheumatological or dermatological data. Berlin is the city with the highest number of non-native German inhabitants, and its multi-ethnic character renders it uniquely appropriate for epidemiological studies on ABD.

Methods

We retrospectively analyzed all ABD patients seen in our department since 1982. All patients fulfilled the criteria of the International Study Group for Behçet’s Disease. We found 140 patients (63 female, 77 male), with a mean follow-up of 6.4 years (0.5–22 years).

Results

The mean age was 23 at the first manifestation and 32 when the full-blown disease was noted. The mean age at onset of ocular involvement was 30. Most of the patients were of Turkish (n = 73) or German (n = 34) origin. Fifty-six percent developed ocular involvement, which was the first manifestation in 8.6% and the second manifestation in 19.3% of cases.

Conclusions

More than half the patients developed ocular involvement. The calculated prevalence of ocular involvement in ABD is 1.77/100,000 inhabitants for the municipality of Berlin.
Literatur
2.
Zurück zum Zitat Kotter I, Vonthein R, Muller CA, Gunaydin I, Zierhut M, Stubiger N (2004) Behcet’s disease in patients of German and Turkish origin living in Germany: a comparative analysis. J Rheumatol 31:133–139PubMed Kotter I, Vonthein R, Muller CA, Gunaydin I, Zierhut M, Stubiger N (2004) Behcet’s disease in patients of German and Turkish origin living in Germany: a comparative analysis. J Rheumatol 31:133–139PubMed
4.
Zurück zum Zitat Zouboulis CC (1999) Epidemiology of Adamantiades-Behcet’s disease. Ann Med Interne (Paris) 150:488–498 Zouboulis CC (1999) Epidemiology of Adamantiades-Behcet’s disease. Ann Med Interne (Paris) 150:488–498
5.
Zurück zum Zitat Papoutsis NG, Abdel-Naser MB, Altenburg A et al (2006) Prevalence of Adamantiades-Behçet’s disease in Germany and the municipality of Berlin: Results of a nationwide survey. Clin Exp Rheumatol 24(suppl 42):S125, Erratum in Clin Exp Rheumatol (2007) 25:507–508PubMed Papoutsis NG, Abdel-Naser MB, Altenburg A et al (2006) Prevalence of Adamantiades-Behçet’s disease in Germany and the municipality of Berlin: Results of a nationwide survey. Clin Exp Rheumatol 24(suppl 42):S125, Erratum in Clin Exp Rheumatol (2007) 25:507–508PubMed
6.
Zurück zum Zitat Altenburg A, Papoutsis N, Orawa H, Martus P, Krause L, Zouboulis CC (2006) Epidemiology and clinical manifestations of Adamantiades-Behcet disease in Germany - current pathogenetic concepts and therapeutic possibilities. J Dtsch Dermatol Ges 4:49–64, quiz 65–66 doi:10.1111/j.1610-0387.2006.05841.x PubMed Altenburg A, Papoutsis N, Orawa H, Martus P, Krause L, Zouboulis CC (2006) Epidemiology and clinical manifestations of Adamantiades-Behcet disease in Germany - current pathogenetic concepts and therapeutic possibilities. J Dtsch Dermatol Ges 4:49–64, quiz 65–66 doi:10.​1111/​j.​1610-0387.​2006.​05841.​x PubMed
7.
Zurück zum Zitat International Study Group for Behcet’s Disease (1990) Criteria for diagnosis of Behcet’s disease. Lancet 335:1078–1080 International Study Group for Behcet’s Disease (1990) Criteria for diagnosis of Behcet’s disease. Lancet 335:1078–1080
9.
Zurück zum Zitat Mishima S, Masuda K, Izawa Y, Mochizuki M, Namba K (1979) The eighth Frederick H. Verhoeff Lecture. presented by Saiichi Mishima, MD Behcet’s disease in Japan: ophthalmologic aspects. Trans Am Ophthalmol Soc 77:225–279PubMed Mishima S, Masuda K, Izawa Y, Mochizuki M, Namba K (1979) The eighth Frederick H. Verhoeff Lecture. presented by Saiichi Mishima, MD Behcet’s disease in Japan: ophthalmologic aspects. Trans Am Ophthalmol Soc 77:225–279PubMed
14.
Zurück zum Zitat Zierhut M, Saal J, Pleyer U, Kotter I, Durk H, Fierlbeck G (1995) Behcet’s disease: epidemiology and eye manifestations in German and Mediterranean patients. Ger J Ophthalmol 4:246–251PubMed Zierhut M, Saal J, Pleyer U, Kotter I, Durk H, Fierlbeck G (1995) Behcet’s disease: epidemiology and eye manifestations in German and Mediterranean patients. Ger J Ophthalmol 4:246–251PubMed
17.
Zurück zum Zitat Ozdal PC, Ortac S, Taskintuna I, Firat E (2002) Posterior segment involvement in ocular Behcet’s disease. Eur J Ophthalmol 12:424–431PubMed Ozdal PC, Ortac S, Taskintuna I, Firat E (2002) Posterior segment involvement in ocular Behcet’s disease. Eur J Ophthalmol 12:424–431PubMed
20.
Zurück zum Zitat Gurler A, Boyvat A, Tursen U (1997) Clinical manifestations of Behcet’s disease: an analysis of 2147 patients. Yonsei Med J 38:423–427PubMed Gurler A, Boyvat A, Tursen U (1997) Clinical manifestations of Behcet’s disease: an analysis of 2147 patients. Yonsei Med J 38:423–427PubMed
22.
Zurück zum Zitat Torres RM, Yanez B, Herreras JM, Calonge M (2004) Ocular Behcet disease. Retrospective study. Arch Soc Esp Oftalmol 79:599–603PubMed Torres RM, Yanez B, Herreras JM, Calonge M (2004) Ocular Behcet disease. Retrospective study. Arch Soc Esp Oftalmol 79:599–603PubMed
23.
Zurück zum Zitat Chung YM, Yeh TS, Sheu MM et al (1990) Behcet’s disease with ocular involvement in Taiwan: a joint survey of six major ophthalmological departments. J Formos Med Assoc 89:413–417PubMed Chung YM, Yeh TS, Sheu MM et al (1990) Behcet’s disease with ocular involvement in Taiwan: a joint survey of six major ophthalmological departments. J Formos Med Assoc 89:413–417PubMed
27.
Zurück zum Zitat Saylan T, Ozarmagan G, Azizlerli G, Ovul C, Oke N (1986) Behcet disease in Turkey. Z Hautkr 61:1120–1122PubMed Saylan T, Ozarmagan G, Azizlerli G, Ovul C, Oke N (1986) Behcet disease in Turkey. Z Hautkr 61:1120–1122PubMed
28.
Zurück zum Zitat Zouboulis CC, Turnbull JR, Martus P (2003) Univariate and multivariate analyses comparing demographic, genetic, clinical, and serological risk factors for severe Adamantiades-Behçet’s Disease. In: Zouboulis CC (ed) Adamantiades-Behçet’s Disease. Kluwer/Plenum, London Amsterdam, pp 123–126 Zouboulis CC, Turnbull JR, Martus P (2003) Univariate and multivariate analyses comparing demographic, genetic, clinical, and serological risk factors for severe Adamantiades-Behçet’s Disease. In: Zouboulis CC (ed) Adamantiades-Behçet’s Disease. Kluwer/Plenum, London Amsterdam, pp 123–126
29.
Zurück zum Zitat Krause L, Köhler AK, Altenburg A et al (2008) Ocular involvement is associated with HLA-B51 in Adamantiades-Behçet’s disease. Eye (Jun):13. Epub ahead of print Krause L, Köhler AK, Altenburg A et al (2008) Ocular involvement is associated with HLA-B51 in Adamantiades-Behçet’s disease. Eye (Jun):13. Epub ahead of print
Metadaten
Titel
Ocular involvement in Adamantiades-Behçet’s disease in Berlin, Germany
verfasst von
Lothar Krause
Anne-Katrin Köhler
Andreas Altenburg
Nestor Papoutsis
Christos C. Zouboulis
Uwe Pleyer
Andrea Stroux
Michael H. Foerster
Publikationsdatum
01.05.2009
Verlag
Springer-Verlag
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 5/2009
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-008-0983-4

Weitere Artikel der Ausgabe 5/2009

Graefe's Archive for Clinical and Experimental Ophthalmology 5/2009 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.